Lv1
20 积分 2025-12-22 加入
Who and how to choose combination therapy for inflammatory bowel disease: a comprehensive expert review
1个月前
已完结
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
1个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
1个月前
已完结
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease
1个月前
已完结
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2个月前
已完结
Agonist signaling drives neutrophil subpopulations to promote/inhibit colorectal cancer liver metastasis
2个月前
已完结
Endothelial RAP1A attenuates sinusoidal capillarisation and liver fibrosis by inhibiting RAF1-mediated Notch activation
4个月前
已完结
Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis
4个月前
已完结
Obesity disrupts ILC2 metabolic and functional homeostasis by inhibiting mTORC1 signaling
4个月前
已完结
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
6个月前
已完结
皖公网安备34019202002308
